{
  "id": 16032,
  "label": "renin-angiotensin-aldosterone system-blocker-induced angioedema",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "MONDO:0015057",
  "properties": {
    "xrefs": [
      "GARD:0016936",
      "MEDGEN:725846",
      "MESH:C535293",
      "Orphanet:100057",
      "SCTID:403607004",
      "UMLS:C1304495"
    ],
    "synonyms": [
      "RAE",
      "Raas-blocker-induced angioedema",
      "Raas-blocker-induced angioneurotic edema",
      "Raas-blocker-induced angioneurotic oedema",
      "renin-angiotensin-aldosterone system-blocker-induced angioneurotic edema",
      "renin-angiotensin-aldosterone system-blocker-induced angioneurotic oedema",
      "AEACEI",
      "angioedema induced by ACE inhibitors, susceptibility to",
      "reactive angioendotheliomatosis",
      "susceptibility to angioedema induced by ace inhibitors"
    ],
    "categories": [
      {
        "ref": "MONDO:0002051",
        "name": "integumentary system disorder"
      },
      {
        "ref": "MONDO:0004995",
        "name": "cardiovascular disorder"
      }
    ],
    "definition": "Renin-angiotensin-aldosterone system (RAAS)-blocker induced angioedema (RAE) is a type of acquired angioedema (AAE) characterized by acute edema in subcutaneous tissues, viscera and/or the upper airway."
  },
  "isLeaf": true,
  "isRoot": false,
  "child_count": 0,
  "parents": [
    {
      "id": 19414,
      "label": "acquired angioedema",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        11639
      ],
      "type_id": 0,
      "properties": {
        "xrefs": [
          "DOID:0080941",
          "GARD:0008605",
          "MEDGEN:419486",
          "MESH:C538173",
          "Orphanet:91385",
          "UMLS:C2931758",
          "icd11.foundation:1078767412"
        ],
        "synonyms": [
          "AAE",
          "acquired C1 inhibitor deficiency",
          "acquired angioedema",
          "acquired angioneurotic edema",
          "acquired angioneurotic oedema",
          "acquired bradykinine-induced angioedema",
          "acquired non histamine-induced angioedema",
          "angioedema, acquired"
        ],
        "categories": [
          {
            "ref": "MONDO:0002051",
            "name": "integumentary system disorder"
          },
          {
            "ref": "MONDO:0004995",
            "name": "cardiovascular disorder"
          }
        ],
        "definition": "Acquired angioedema (AAE) is characterized by the occurrence of transitory and recurrent subcutaneous and/or submucosal edemas resulting in swelling and/or abdominal pain due to an acquired C1 inhibitor (C1-INH) deficiency."
      },
      "child_count": 5,
      "reference_id": "MONDO:0019624"
    }
  ],
  "children": [],
  "roots": [
    {
      "id": 19414,
      "label": "acquired angioedema"
    }
  ]
}